![Benjamin Rush Field](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Benjamin Rush Field
Direttore/Membro del Consiglio presso USL Pharma International UK Ltd.
Profilo
Benjamin Rush Field has held director positions at Proximagen Group Plc and USL Pharma International UK Ltd.
Currently, he holds director positions at both companies.
Posizioni attive di Benjamin Rush Field
Società | Posizione | Inizio |
---|---|---|
USL Pharma International UK Ltd.
![]() USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 16/04/2015 |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 16/04/2015 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
USL Pharma International UK Ltd.
![]() USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Benjamin Rush Field